股票行情快报:联影医疗(688271)11月18日主力资金净卖出3508.96万元

Core Viewpoint - The stock of United Imaging Healthcare (688271) has shown a slight increase, with a closing price of 134.25 yuan on November 18, 2025, reflecting a 0.19% rise, amidst mixed capital flows [1][2]. Financial Performance - For the first three quarters of 2025, United Imaging Healthcare reported a main business revenue of 8.859 billion yuan, a year-on-year increase of 27.39% [3]. - The net profit attributable to shareholders for the same period was 1.12 billion yuan, up 66.91% year-on-year [3]. - The third quarter of 2025 saw a single-quarter main business revenue of 2.843 billion yuan, representing a 75.41% increase year-on-year [3]. - The net profit for the third quarter was 122 million yuan, a significant rise of 143.8% year-on-year [3]. - The company’s gross profit margin stands at 47.02%, while the net profit margin is 12.44% [3]. Market Position - United Imaging Healthcare has a total market capitalization of 110.643 billion yuan, ranking 2nd in the medical device industry [3]. - The company’s net assets amount to 20.805 billion yuan, placing it 3rd in the industry [3]. - The price-to-earnings ratio (P/E) is 74.08, which is higher than the industry average of 55.31, ranking 64th [3]. - The price-to-book ratio (P/B) is 5.32, compared to the industry average of 4.04, ranking 104th [3]. Capital Flow Analysis - On November 18, 2025, the net outflow of main capital was 35.0896 million yuan, accounting for 6.46% of the total transaction amount [1][2]. - Retail investors saw a net inflow of 15.9243 million yuan, representing 2.93% of the total transaction amount [1][2]. - Over the past five days, the stock has experienced significant fluctuations in capital flow, with notable net outflows on several days [2]. Analyst Ratings - In the last 90 days, 27 institutions have provided ratings for United Imaging Healthcare, with 20 buy ratings and 7 hold ratings [4]. - The average target price set by institutions over the past 90 days is 175.45 yuan [4].